10-K: Hawkins Inc. Reports Strong Sales Growth in FY2026

Hawkins, Inc. announced fiscal year 2026 results, with sales increasing 11% to $1.08 billion, driven by acquisitions and growth in Water Treatment and Industrial Solutions segments.

Summary

• Hawkins, Inc. reported total sales of $1,083.7 million for fiscal year 2026, an increase of 11% ($109.3 million) compared to fiscal year 2025.
• Gross profit rose by 9% to $245.1 million, while operating income saw a 2% increase to $121.3 million.
• Diluted earnings per share (EPS) were $3.91, a slight decrease of 3% from the prior year, but pro forma diluted EPS increased by 9% to $3.95.
• The company completed six acquisitions in fiscal 2026, totaling approximately $48 million in aggregate annual revenue, with the largest being WaterSurplus for $149.9 million.
• The Water Treatment segment experienced significant sales growth of 22%, while the Industrial Solutions segment grew by 7%. The Food and Health Sciences segment saw a slight decline of 1% in sales.
• Operating cash flow increased by 30% to $144.3 million.
• The company maintained effective internal controls over financial reporting.
• The company's credit facility was increased to $400 million, with $244 million outstanding as of March 29, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive filing, with strong sales growth and improved operating cash flow, despite a slight dip in EPS. The successful integration of multiple acquisitions and continued compliance with financial covenants are key strengths.

Positives

• Total sales increased by 11% to $1,083.7 million in fiscal year 2026.
• Gross profit increased by 9% to $245.1 million.
• Operating income increased by 2% to $121.3 million.
• Operating cash flow increased by 30% to $144.3 million.
• Water Treatment segment sales grew by 22%.
• Industrial Solutions segment sales grew by 7%.
• Pro forma diluted EPS increased by 9% to $3.95.
• The company successfully integrated six acquisitions in fiscal year 2026.
• Effective internal control over financial reporting was maintained.
• The company is in compliance with all covenants under its credit agreement.

Negatives

• Diluted earnings per share (EPS) decreased by 3% to $3.91.
• Food and Health Sciences segment sales decreased by 1%.

Risks

• Intense competition and price pressure from larger competitors with greater financial resources.
• Potential for product liability claims, recalls, and related adverse publicity.
• Changes in customer needs or failure of products to meet requirements could impact sales.
• Adverse publicity or negative public perception regarding ingredients or products could affect financial performance.
• Failure to adequately protect critical data and technology systems from cyber threats.
• Fluctuations in the prices and availability of raw materials, which may be cyclical.
• Demand for products is affected by general economic conditions and the cyclical nature of served industries.
• Hazards common to chemical businesses (fires, explosions, spills) could interrupt production.
• Environmental problems at facilities could result in significant unexpected costs.
• Seasonality and weather conditions impacting the Water Treatment and agricultural product sales.
• Disruptions within the supply chain and transportation network can negatively impact operations.
• Inability to retain key personnel or attract new skilled personnel.
• Risks associated with consummating and integrating future acquisitions.
• Potential for natural disasters or other extraordinary events to interrupt production.
• Impacts from tariffs or changes in international trade policies.
• Risk of not being able to renew leases for key operational facilities.
• Substantial costs and potential future liabilities related to environmental, health, safety, transportation, and storage regulations.
• Government regulation of food, pharmaceutical, and health/nutrition products could increase costs and limit sales.
• Insurance may not fully cover all potential exposures.
• Failure to comply with covenants under the credit facility could lead to default.
• Impairment to the carrying value of goodwill or other intangible assets.

Future Outlook

The company anticipates total capital expenditures to be approximately $55 million for fiscal year 2027. Management believes that existing cash, cash generated from operations, and available borrowings under the credit agreement will be sufficient to meet working capital and expenditure requirements for at least the next 12 months. The company expects to remain in compliance with all covenants of its credit agreement for the next 12 months.

Management Comments

• We believe that we create value for our customers through superb service and support, quality products, personalized applications and trustworthy, creative employees.
• We focus on total profitability dollars when evaluating our financial results as opposed to profitability as a percentage of sales, as sales dollars tend to fluctuate as raw material prices rise and fall, particularly in our Water Treatment and Industrial Solutions segments.
• We believe that our existing cash and cash equivalents, together with cash generated from operations and available borrowings under our existing Credit Agreement, will be sufficient to meet our working capital expenditure requirements for at least the next 12 months.

Industry Context

StockSavvy.ai notes that Hawkins, Inc.'s performance in fiscal year 2026, particularly the 11% sales growth, reflects a resilient demand in its core Water Treatment and Industrial Solutions segments, despite a slight dip in Food and Health Sciences. The company's strategy of acquiring businesses and integrating them into its existing structure, as evidenced by the significant WaterSurplus acquisition, aligns with industry trends of consolidation and expansion in specialty chemical and ingredient markets.

Legal Proceedings

• There are no material pending legal proceedings, other than ordinary routine litigation incidental to the business, to which Hawkins, Inc. or any of its subsidiaries is a party or of which any of its property is the subject.

Stakeholder Impact

• Shareholders: The company's sales growth and strategic acquisitions may lead to increased shareholder value, though the slight decrease in EPS warrants monitoring.
• Employees: The company emphasizes employee health and safety, competitive wages, and benefits, including 401(k) and ESOP plans. Continued growth may lead to further employment opportunities.
• Customers: The company aims to provide superb service, quality products, and personalized applications, with a focus on being a trusted expert in water treatment and a one-stop ingredient solutions provider.
• Suppliers: The company relies on numerous suppliers and has distributorship agreements or supply contracts, with the belief that most products can be obtained from alternative sources if needed.
• Creditors: The company's compliance with its credit facility covenants and its financial performance are key to maintaining its relationship with lenders.

Next Steps

• Continue to invest in existing and new branches to expand geographic coverage in the Water Treatment segment.
• Continue to pursue acquisitions that complement or expand existing businesses or increase customer base.
• Continue to manage interest rate risk through the existing interest rate swap agreement.
• Anticipate total capital expenditures of approximately $55 million for fiscal year 2027.

Key Dates

Recommendation

Hawkins, Inc. demonstrates solid revenue growth and operational improvements, particularly in its Water Treatment and Industrial Solutions segments, bolstered by strategic acquisitions. However, the slight decrease in diluted EPS and the ongoing competitive pressures and risks outlined in the filing suggest a 'hold' recommendation. Investors should monitor the integration of recent acquisitions and the company's ability to translate revenue growth into stronger bottom-line performance.

Keywords

Hawkins Inc., 10-K, Annual Report, Water Treatment, Specialty Ingredients, Food and Health Sciences, Industrial Solutions, Financial Results, Sales Growth, Acquisitions, SEC Filing